Document is current
Any future updates will be listed below
-
Authors
Verbeek, Tamara C. A. I. https://orcid.org/0000-0001-5116-6762
Vrenken, Kirsten S.
Arentsen-Peters, Susan T. C. J. M.
Castro, Patricia Garrido
van de Ven, Marieke https://orcid.org/0000-0001-6779-9353
van Tellingen, Olaf
Pieters, Rob
Stam, Ronald W.
-
Funding
Funding for this research was provided by:
Stichting Kinderen Kankervrij (KiKa-236)
KWF Kankerbestrijding (KWF-11863)
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 17 September 2024
First Online: 4 October 2024
Competing interests
: The authors declare no competing interests.
: All animal experiments, if not stated differently, were carried out according to Dutch legislation and approved by the Animal Ethics Committee (Approval Number: AVD3990020173066 & AVD39900202216167) at the Princess Máxima Center, Utrecht, The Netherlands. The pharmacokinetics study for LMK-235 was approved by the Animal Ethics Committee (Approval Number: AVD301002016407) at the Netherlands Cancer Institute, Amsterdam, The Netherlands.
